Back to search

Aida Oncology Limited

12557227

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

LONDON BIOSCIENCE INNOVATION CENTRE, LONDON, NW1 0NH
Incorporated 15/04/2020

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Peter Buhl

director · Since 15/04/2020

DIRECTOR

DANISH · DENMARK · Age 71

Mr Neil Goldsmith

director · Since 15/04/2020

DIRECTOR

BRITISH · DENMARK · Age 63

Also on 2 other boards

Mr Andrew David Gardiner

director · Since 03/03/2021

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 63

Also on 2 other boards

Persons with Significant Control

Mr Peter Buhl

50–75% shares
50–75% votes
Appoint directors

Danish · Denmark · Age 71

London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH

Notified 15/04/2020

CompanyRankvs 2262+ SIC 72110 peers
43

Financial strength53th percentile among SIC peers · 13/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 0.68× · 6/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
2262Aida Oncology Limited
39
How is this score calculated?
Financial strength13/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/04/2025

Net Worth

£1k

Balance sheet strength

Cash

£16k

Cash in the bank

Net Current Assets

-£11k

Working capital

Current Assets

£22k

Current Liabilities

£33k

Debtors

£6k

0avg. employees

Balance Sheet

Assets less current liabilities-£11k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent Ratio
20250.68
20240.72
20230.77
20220.87
20210.79

Derived from filed accounts. Not audited figures.